Improved screening of retinopathy of prematurity (ROP): development of a target product profile (TPP) for resource-limited settings
Authors:
Open Access
- 17 July 2023
- journal article
- research article
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 8 (1) , e001197
Abstract
Background As more preterm infants survive, complications of preterm birth, including retinopathy of prematurity (ROP), become more prevalent. ROP rates and blindness from ROP are higher in low-income and middle-income countries, where exposure to risk factors can be higher and where detection and treatment of ROP are under-resourced or non-existent. Access to low-cost imaging devices would improve remote screening capabilities for ROP. Methods Target product profiles (TPPs) are developed early in the medical device development process to define the setting, target user and range of product requirements. A Delphi-like process, consisting of an online survey and consensus meeting, was used to develop a TPP for an ROP imaging device, collecting feedback on a proposed set of 64 product requirements. Results Thirty-six stakeholders from 17 countries provided feedback: clinicians (72%), product developers (14%), technicians (6%) and other (8%). Thirty-six per cent reported not currently screening for ROP, with cited barriers including cost (44%), no training (17%) and poor image quality (16%). Among those screening (n=23), 48% use more than one device, with the most common being an indirect ophthalmoscope (87%), followed by RetCam (26%) and smartphone with image capture (26%). Consensus was reached on 53 (83%) product requirements. The 11 remaining were discussed at the consensus meeting, and all but two achieved consensus. Conclusions This TPP process was novel in that it successfully brought together diverse stakeholders to reach consensus on the product requirements for an ROP imaging devices. The resulting TPP provides a framework from which innovators can develop prototypes.Keywords
Funding Information
- John D. and Catherine T. MacArthur Foundation (NEST360)
- Bill and Melinda Gates Foundation (NEST360 - INV007756)
- Ting Tsung and Wei Fong Chao Foundation (NEST360)
- Lemelson Foundation (NEST360)
- Children’s Investment Fund Foundation (NEST360)
- The Elma Foundation (NEST360)
This publication has 12 references indexed in Scilit:
- Smartphone based ROP (S-ROP) screening—opportunities and challengesEye, 2020
- Retinopathy of prematurity: a review of risk factors and their clinical significanceSurvey of Ophthalmology, 2018
- Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profileBMC Infectious Diseases, 2017
- Survival and Major Morbidity of Extremely Preterm Infants: A Population-Based StudyPediatrics, 2016
- Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemicEye and Brain, 2016
- Potential for a paradigm change in the detection of retinopathy of prematurity requiring treatmentArchives of Disease in Childhood - Fetal and Neonatal Edition, 2015
- New technologies for essential newborn care in under-resourced areas: what is needed and how to deliver itPaediatrics and International Child Health, 2015
- Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010Pediatric Research, 2013
- The Incidence and Course of Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity StudyPediatrics, 2005
- Neonatal survival: a call for actionThe Lancet, 2005